Seven Centres of Excellence Set Up Under PRIP Scheme
ECONOMY & POLICY

Seven Centres of Excellence Set Up Under PRIP Scheme

The Department of Pharmaceuticals has established seven Centres of Excellence (CoEs), one at each of the seven National Institutes of Pharmaceutical Education and Research (NIPERs), under Component A of the Promotion of Research and Innovation in MedTech Sector (PRIP) scheme. A total amount of Rs 1,834.6 million (mn) has been released for setting up these centres up to 31 January 2026. The centres are intended to strengthen institutional capacity and support translational research in the MedTech sector. They will facilitate partnerships and resource sharing among NIPERs and industry partners to advance applied research.

A total of 710 research projects were received from industry, start-ups and MSMEs by the closing date of 19 November 2025, including projects in priority areas that are eligible for higher financial support under the PRIP scheme. Approval for financial assistance under the scheme, including full funding assistance and higher funding assistance to eligible projects, is provided after a multi-stage appraisal process as prescribed under the scheme guidelines.

The information was supplied by the Union Minister of State for Chemicals and Fertilizers, Anupriya Patel, in a written reply to the Rajya Sabha. The initiative is designed to promote collaboration between academic institutions and the private sector, facilitate technology transfer and nurture start-ups that can translate research into marketable medical devices and solutions. The ministerial reply set out the number of projects received and the financial assistance framework under the scheme.

The scheme is intended to ensure that priority projects receive necessary support through prescribed appraisal and funding mechanisms and to strengthen the pipeline from laboratory research to clinical and commercial application. Officials expect the Centres of Excellence to offer specialised facilities, training and industry engagement that should accelerate the development and deployment of MedTech innovations across the country. The department will continue to monitor progress and disbursement of funds as projects proceed through appraisal stages.

The Department of Pharmaceuticals has established seven Centres of Excellence (CoEs), one at each of the seven National Institutes of Pharmaceutical Education and Research (NIPERs), under Component A of the Promotion of Research and Innovation in MedTech Sector (PRIP) scheme. A total amount of Rs 1,834.6 million (mn) has been released for setting up these centres up to 31 January 2026. The centres are intended to strengthen institutional capacity and support translational research in the MedTech sector. They will facilitate partnerships and resource sharing among NIPERs and industry partners to advance applied research. A total of 710 research projects were received from industry, start-ups and MSMEs by the closing date of 19 November 2025, including projects in priority areas that are eligible for higher financial support under the PRIP scheme. Approval for financial assistance under the scheme, including full funding assistance and higher funding assistance to eligible projects, is provided after a multi-stage appraisal process as prescribed under the scheme guidelines. The information was supplied by the Union Minister of State for Chemicals and Fertilizers, Anupriya Patel, in a written reply to the Rajya Sabha. The initiative is designed to promote collaboration between academic institutions and the private sector, facilitate technology transfer and nurture start-ups that can translate research into marketable medical devices and solutions. The ministerial reply set out the number of projects received and the financial assistance framework under the scheme. The scheme is intended to ensure that priority projects receive necessary support through prescribed appraisal and funding mechanisms and to strengthen the pipeline from laboratory research to clinical and commercial application. Officials expect the Centres of Excellence to offer specialised facilities, training and industry engagement that should accelerate the development and deployment of MedTech innovations across the country. The department will continue to monitor progress and disbursement of funds as projects proceed through appraisal stages.

Related Stories

Gold Stories

Next Story
Products

Koemmerling opens Navi Mumbai experience centre

Koemmerling, a brand of the profine Group, has expanded its presence in the Mumbai metropolitan region with the opening of a new experience centre in Navi Mumbai and launched its Allure S46 minimal sliding door system for the Indian market.Located in CBD Belapur, the facility was inaugurated by Peter Mrosik, Owner and CEO, profine Group, along with Farid Khan, Chairman and Managing Director, profine India, and Kamal Bajaj, CEO, profine India.The company said the new centre will showcase its portfolio of uPVC and aluminium window and door systems to architects, developers and homeowners.The ina..

Next Story
Products

India's waterproofing market nears Rs 150 bn milestone

India's waterproofing industry is approaching a market size of Rs 150 billion and is expected to surpass the $2 billion milestone, according to speakers at the 2nd India International Waterproofers Conference & Expo 2026 organised by the Waterproofers Association of India (WAI) in New Delhi.The two-day event brought together more than 20 speakers, 55 international delegates and 53 exhibition booths, with discussions focusing on climate-resilient construction, advanced waterproofing technologies and international collaboration.Inaugurating the event, Durga Shanker Mishra, former Secretary, ..

Next Story
Real Estate

Dilip Buildcon Q1 FY27 Revenue at Rs 23.78 billion

Dilip Buildcon Limited reported consolidated revenue from operations of Rs 2,378 crore in Q1 FY27, along with EBITDA of Rs 429 crore and profit after tax of Rs 128 crore.Consolidated EBITDA margin stood at 18.1%, improving from 17.1% in Q4 FY26. On a standalone basis, revenue from operations was Rs 1,930 crore, EBITDA stood at Rs 199 crore and PAT was Rs 39 crore, with an EBITDA margin of 10.3%.The company’s order book stood at Rs 27,691 crore as of 30 June 2026, compared with Rs 28,830 crore as of 31 March 2026. Roads and highways accounted for 17.1% of the order book, irrigation and water ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement